Alison Cave

5.4k total citations · 1 hit paper
46 papers, 4.0k citations indexed

About

Alison Cave is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Alison Cave has authored 46 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 19 papers in Cardiology and Cardiovascular Medicine and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Alison Cave's work include Nitric Oxide and Endothelin Effects (19 papers), Cardiac Ischemia and Reperfusion (17 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (11 papers). Alison Cave is often cited by papers focused on Nitric Oxide and Endothelin Effects (19 papers), Cardiac Ischemia and Reperfusion (17 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (11 papers). Alison Cave collaborates with scholars based in United Kingdom, Netherlands and United States. Alison Cave's co-authors include Ajay M. Shah, David Grieve, Jennifer K. Bendall, Christophe Heymes, Simon Walker, Alison C. Brewer, Robin Ray, Nicholas Gall, Jonathan Byrne and Xavier Kurz and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Alison Cave

43 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NADPH Oxidases in Cardiovascular Health and Disease

2006 511 citations Alison Cave, Alison C. Brewer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Cave United Kingdom	25	1.5k	1.4k	1.3k	917	730	46	4.0k
Diego Rodrı́guez-Puyol Spain	37	635 0.4×	1.0k 0.8×	1.5k 1.2×	503 0.5×	466 0.6×	172	4.6k
Karsten Sydow Germany	29	1.7k 1.1×	2.0k 1.4×	749 0.6×	554 0.6×	278 0.4×	53	4.3k
Bernard L. Lopez United States	37	1.2k 0.7×	1.3k 1.0×	1.4k 1.1×	330 0.4×	1.1k 1.4×	94	4.6k
Theodore A. Christopher United States	38	1.4k 0.9×	1.4k 1.0×	1.6k 1.3×	352 0.4×	1.1k 1.5×	92	4.8k
Daniela Fraccarollo Germany	36	2.0k 1.3×	1.1k 0.8×	1.5k 1.2×	435 0.5×	308 0.4×	96	4.5k
Jan Galle Germany	37	927 0.6×	1.0k 0.8×	1.3k 1.1×	1.2k 1.3×	178 0.2×	82	4.3k
Xin L. United States	27	1.1k 0.7×	1.0k 0.7×	1.3k 1.0×	294 0.3×	812 1.1×	44	3.4k
Tetsuya Shiomi Japan	23	1.1k 0.7×	662 0.5×	1.0k 0.8×	326 0.4×	321 0.4×	50	2.9k
Maristela L. Onozato United States	33	750 0.5×	920 0.7×	923 0.7×	395 0.4×	179 0.2×	73	3.9k
Shoji Sanada Japan	33	2.0k 1.3×	572 0.4×	1.4k 1.1×	1.1k 1.1×	806 1.1×	98	4.9k

Countries citing papers authored by Alison Cave

Since Specialization

Citations

This map shows the geographic impact of Alison Cave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Cave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Cave more than expected).

Fields of papers citing papers by Alison Cave

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Cave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Cave. The network helps show where Alison Cave may publish in the future.

Co-authorship network of co-authors of Alison Cave

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Cave. A scholar is included among the top collaborators of Alison Cave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Cave. Alison Cave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Booth, Helen, John Connelly, Daniel Dedman, Katherine Donegan, & Alison Cave. (2025). A Regulatory Perspective on a UK Federated Data Network for Medicines and Medical Devices: Lessons from a ‘Study-A-Thon’. Therapeutic Innovation & Regulatory Science. 60(1). 1–7.

Cave, Alison. (2024). The prescription of valproate: risk of harm. The Lancet Neurology. 23(6). 557–557. 1 indexed citations

Gini, Rosa, Miriam Sturkenboom, Janet Sultana, et al.. (2020). Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model. Clinical Pharmacology & Therapeutics. 108(2). 228–235. 36 indexed citations

Plueschke, Kelly, Patricia McGettigan, Alexandra Păcurariu, Xavier Kurz, & Alison Cave. (2018). EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making. BMJ Open. 8(6). e021864–e021864. 26 indexed citations

Păcurariu, Alexandra, Kelly Plueschke, Patricia McGettigan, et al.. (2018). Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation. BMJ Open. 8(9). e023090–e023090. 39 indexed citations

Murdoch, Colin E., Sanjay Chaubey, Lingfang Zeng, et al.. (2014). Endothelial NADPH Oxidase-2 Promotes Interstitial Cardiac Fibrosis and Diastolic Dysfunction Through Proinflammatory Effects and Endothelial-Mesenchymal Transition. Journal of the American College of Cardiology. 63(24). 2734–2741. 165 indexed citations

Chaubey, Sanjay, Gareth E. Jones, Ajay M. Shah, Alison Cave, & Claire M. Wells. (2013). Nox2 Is Required for Macrophage Chemotaxis towards CSF-1. PLoS ONE. 8(2). e54869–e54869. 25 indexed citations

Cave, Alison. (2008). Selective targeting of NADPH oxidase for cardiovascular protection. Current Opinion in Pharmacology. 9(2). 208–213. 53 indexed citations

Grieve, David, Jonathan Byrne, Anjana Siva, et al.. (2006). Involvement of the Nicotinamide Adenosine Dinucleotide Phosphate Oxidase Isoform Nox2 in Cardiac Contractile Dysfunction Occurring in Response to Pressure Overload. Journal of the American College of Cardiology. 47(4). 817–826. 117 indexed citations

10.

Cave, Alison, et al.. (2004). Pivotal role of gp91phox-containing NADPH oxidase in early ischemic preconditioning. Journal of Molecular and Cellular Cardiology. 37(1). 178–179. 1 indexed citations

11.

Grieve, David, Alison Cave, Jonathan Byrne, Joanne Layland, & Ajay M. Shah. (2004). Analysis of ex vivo left ventricular pressure–volume relations in the isolated murine ejecting heart. Experimental Physiology. 89(5). 573–582. 16 indexed citations

12.

Grieve, David, Jonathan Byrne, Alison Cave, & Ajay M. Shah. (2004). Role of Oxidative Stress in Cardiac Remodelling after Myocardial Infarction. Heart Lung and Circulation. 13(2). 132–138. 86 indexed citations

13.

Cave, Alison, et al.. (2003). Ischemic preconditiong: Pivotal role of gp91(phox)-containing NADPH oxidase in oxidative signalling. Journal of Molecular and Cellular Cardiology. 35(11). 1 indexed citations

14.

Grieve, David, Jonathan Byrne, Alison Cave, & Ajay M. Shah. (2002). Cardiac contractile dysfunction and fibrosis induced by chronic pressure overload are inhibited in gp91phox-null mice. The Journal of Physiology. 106(19). 2 indexed citations

15.

Bendall, Jennifer K., Christophe Heymes, Stephen B. Wheatcroft, et al.. (2002). Strain-Dependent Variation in Vascular Responses to Nitric Oxide in the Isolated Murine Heart. Journal of Molecular and Cellular Cardiology. 34(10). 1325–1333. 35 indexed citations

16.

Cave, Alison & Pamela B. Garlick. (2000). Is a Functional Sarcoplasmic Reticulum Necessary for Preconditioning?. Journal of Molecular and Cellular Cardiology. 32(3). 415–427. 5 indexed citations

17.

Garlick, Pamela B., Harold G. Parkes, & Alison Cave. (2000). A New System for the Metabolic Investigation of the Isolated, Perfused Rat Heart. Journal of Molecular and Cellular Cardiology. 32(5). 853–858. 2 indexed citations

18.

Garlick, Pamela B., Paul Marsden, Alison Cave, et al.. (1997). PET and NMR dual acquisition (PANDA): applications to isolated, perfused rat hearts. NMR in Biomedicine. 10(3). 138–142. 64 indexed citations

19.

Cave, Alison & Carl S. Apstein. (1996). Polymyxin B, a Protein Kinase C Inhibitor, Abolishes Preconditioning-induced Protection against Contractile Dysfunction in the Isolated Blood Perfused Rat Heart. Journal of Molecular and Cellular Cardiology. 28(5). 977–987. 17 indexed citations

20.

Zhai, Xiaolin, Clive S. Lawson, Alison Cave, & David J. Hearse. (1993). Preconditioning and Post-ischaemic Contractile Dysfunction: the Role of Impaired Oxygen Delivery vs Extracellular Metabolite Accumulation. Journal of Molecular and Cellular Cardiology. 25(7). 847–857. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact